Lauren Sherman[Author] - Search Results

Year	Number of Results
2008	1
2010	1
2011	1
2012	2
2013	1
2014	2
2015	3
2016	5
2017	4
2018	5
2019	5
2021	5
2022	1
2023	6
2024	4

1

Deficit, difference, or both? Autism and neurodiversity.

Kapp SK, Gillespie-Lynch K, Sherman LE, Hutman T. Kapp SK, et al. Among authors: sherman le. Dev Psychol. 2013 Jan;49(1):59-71. doi: 10.1037/a0028353. Epub 2012 Apr 30. Dev Psychol. 2013. PMID: 22545843

2

The Power of the Like in Adolescence: Effects of Peer Influence on Neural and Behavioral Responses to Social Media.

Sherman LE, Payton AA, Hernandez LM, Greenfield PM, Dapretto M. Sherman LE, et al. Psychol Sci. 2016 Jul;27(7):1027-35. doi: 10.1177/0956797616645673. Epub 2016 May 31. Psychol Sci. 2016. PMID: 27247125 Free PMC article.

3

Mesenchymal stem cell therapies in brain disease.

Sherman LS, Romagano MP, Williams SF, Rameshwar P. Sherman LS, et al. Semin Cell Dev Biol. 2019 Nov;95:111-119. doi: 10.1016/j.semcdb.2019.03.003. Epub 2019 Apr 4. Semin Cell Dev Biol. 2019. PMID: 30922957 Review.

4

Mesenchymal stromal/stem cells in drug therapy: New perspective.

Sherman LS, Shaker M, Mariotti V, Rameshwar P. Sherman LS, et al. Cytotherapy. 2017 Jan;19(1):19-27. doi: 10.1016/j.jcyt.2016.09.007. Epub 2016 Oct 17. Cytotherapy. 2017. PMID: 27765601 Review.

5

Non-coding RNA as mediators in microenvironment-breast cancer cell communication.

Patel JS, Hu M, Sinha G, Walker ND, Sherman LS, Gallagher A, Rameshwar P. Patel JS, et al. Among authors: sherman ls. Cancer Lett. 2016 Sep 28;380(1):289-95. doi: 10.1016/j.canlet.2015.11.016. Epub 2015 Nov 12. Cancer Lett. 2016. PMID: 26582656 Review.

6

Impaired receptivity of thin endometrium: therapeutic potential of mesenchymal stem cells.

Saad-Naguib MH, Kenfack Y, Sherman LS, Chafitz OB, Morelli SS. Saad-Naguib MH, et al. Among authors: sherman ls. Front Endocrinol (Lausanne). 2024 Jan 25;14:1268990. doi: 10.3389/fendo.2023.1268990. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38344687 Free PMC article. Review.

7

Stem cell delivery of therapies for brain disorders.

Aleynik A, Gernavage KM, Mourad YSh, Sherman LS, Liu K, Gubenko YA, Rameshwar P. Aleynik A, et al. Among authors: sherman ls. Clin Transl Med. 2014 Jul 19;3:24. doi: 10.1186/2001-1326-3-24. eCollection 2014. Clin Transl Med. 2014. PMID: 25097727 Free PMC article. Review.

8

A discussion on adult mesenchymal stem cells for drug delivery: pros and cons.

Sherman LS, Condé-Green A, Sandiford OA, Rameshwar P. Sherman LS, et al. Ther Deliv. 2015;6(12):1335-46. doi: 10.4155/tde.15.80. Ther Deliv. 2015. PMID: 26652280 Review.

9

Connecting brain responsivity and real-world risk taking: Strengths and limitations of current methodological approaches.

Sherman L, Steinberg L, Chein J. Sherman L, et al. Dev Cogn Neurosci. 2018 Oct;33:27-41. doi: 10.1016/j.dcn.2017.05.007. Epub 2017 Jun 27. Dev Cogn Neurosci. 2018. PMID: 28774477 Free PMC article. Review.

10

The impact of ovarian stimulation on the human endometrial microenvironment.

Chemerinski A, Shen M, Valero-Pacheco N, Zhao Q, Murphy T, George L, Lemenze A, Sherman L, Heller D, Chen X, Wu T, McGovern PG, Morelli SS, Arora R, Beaulieu AM, Douglas NC. Chemerinski A, et al. Among authors: sherman l. Hum Reprod. 2024 May 2;39(5):1023-1041. doi: 10.1093/humrep/deae048. Hum Reprod. 2024. PMID: 38511208

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

39 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year